() At the world's largest manufacturers of medical devices — United States Medtronic company announced, planned on two drug-eluting heart stent security clinical evaluation conducted randomly. This will be the largest-ever study of similar.
The media here 22 reported that the study involves two drug-eluting heart stent from Medtronic company and United States Johnson company production. Research projects in Europe and other places of 200 clinics for about 8000 patients, mainly to investigate these patients with drug-eluting heart stent installed after thrombosis.
In charge of the study, Belgium cardiovascular disease expert, Dr. Wayne said that previously there is no a large randomized clinical trials with drug-eluting heart stent security as research priorities. Wijns pointed out that the new study is expected to be on drug-eluting heart stent in actual clinical safety gives more thorough and long-term assessment of the research data will help doctors to better balance the bracket of the safety and effectiveness.
In September at the World Congress on heart disease, some experts cite the latest research findings, installation of drug-eluting heart stent thrombosis risk patients than bare metal stent installed ordinary patients. Drug-eluting heart stent security therefore once again become a topic of concern to the medical profession.
No comments:
Post a Comment